Obstetrics & Gynecology Doctors in San Clemente, CA Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

John Russell Gorny, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 665 Camino De Los Mares, Suite 203a, San Clemente, CA 92673 Phone: 949-661-3101    Fax: 949-661-2865

Dr. Anthony T Ledonne, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 16 Corte Vizcaya, San Clemente, CA 92673 Phone: 949-369-5799

Dr. Sandhya Gandhi, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 14 Via Cancha, San Clemente, CA 92673 Phone: 949-770-5678

Dr. Christine Katherine Hrountas, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1303 Avenida De Verdes, San Clemente, CA 92672 Phone: 949-388-4173    Fax: 949-388-4173

Dr. Bijan Bagher Moridani, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 803 Avenida Presidio, San Clemente, CA 92672 Phone: 949-525-1674

News Archive

UVA to launch Mid-Atlantic Telehealth Resource Center in early October

To help patients in the mid-Atlantic states access specialty care and reduce the burden of travel for healthcare, the University of Virginia Center for Telehealth will collaborate with a coalition of healthcare providers to expand telemedicine services with support from a federal grant.

Recent ban on trans fats may not affect the food industry, says food scientist

A recent ban on trans fats may have you looking a little closer at the foods you buy, but a Kansas State University food scientist points out you might not find what you're looking for on the label.

Many patients with knee, hip and spine osteoarthritis use opioids to manage chronic pain

A large percentage of patients with end-stage knee, hip and spine osteoarthritis use opioids to manage their chronic pain, especially those who are younger or have symptoms of depression, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Nektar Therapeutics announced today that the first patients have been dosed in a new Phase 1 dose-escalation clinical study to evaluate NKTR-102, the company's lead oncology compound, in combination with 5-fluorouracil (5-FU)/leucovorin in refractory solid tumor cancers. The study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio.

Study reveals correlation between suicide risk and number of convictions

"The association is clear, even when controlling for risk factors such as substance abuse and mental illness," says Emma Björkenstam of the Swedish National Board of Health and Welfare and Doctoral Student at the medical university Karolinska Institutet.

Read more Medical News

› Verified 2 days ago